Background: Whether people experiencing homelessness (PEH) have different COVID-19 outcomes than housed patients in Canada remains unclear. We sought to ascertain whether rates of in-hospital ...
Outcomes for people experiencing homelessness with COVID-19 presenting to emergency departments in Canada, compared with housed patients ...
Five Things to Know About ...: Glucagon-like peptide-1 receptor agonists for treating chronic kidney disease in patients with type 2 diabetes ...
Les agonistes du récepteur du peptide-1 de type glucagon (GLP-1) sont utilisés pour le traitement du diabète, de l’obésité, et du syndrome des ovaires polykystiques (SOPK) Le sémaglutide, le ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results